301 related articles for article (PubMed ID: 19731813)
21. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
22. Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.
Karlinski M; Kobayashi A; Czlonkowska A; Mikulik R; Vaclavik D; Brozman M; Gdovinova Z; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Bašic-Kes V; Vilionskis A; Jatuzis D; Krespi Y; Shamalov N; Andonova S; Ahmed N; Wahlgren N;
Stroke; 2015 Nov; 46(11):3184-9. PubMed ID: 26451024
[TBL] [Abstract][Full Text] [Related]
23. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
[TBL] [Abstract][Full Text] [Related]
24. [Acute ischemic stroke: time is brain!].
Larrue V
Rev Prat; 2006 Sep; 56(13):1418-23. PubMed ID: 17002067
[TBL] [Abstract][Full Text] [Related]
25. [Thrombolysis in acute ischemic stroke with intravenous recombinant tissue-type plasminogen activator].
May Z; Kakuk I; Ováry C; Ricsóy G; Skopál J; Szegedi N; Varga D; Nagy Z
Orv Hetil; 2002 Nov; 143(44):2479-84. PubMed ID: 12674802
[TBL] [Abstract][Full Text] [Related]
26. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
27. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].
Paris C; Derex L
Rev Neurol (Paris); 2015 Dec; 171(12):866-75. PubMed ID: 26563662
[TBL] [Abstract][Full Text] [Related]
28. Acute ischemic stroke management.
Atkinson RP; DeLemos C
Thromb Res; 2000 May; 98(3):97-111. PubMed ID: 10812162
[TBL] [Abstract][Full Text] [Related]
29. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
30. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator.
Tari Capone F; Cavallari M; Casolla B; Orzi F
Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298
[TBL] [Abstract][Full Text] [Related]
31. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
32. Thrombolysis in dementia patients with acute stroke: is it justified?
Paciaroni M; Pantoni L
Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
[TBL] [Abstract][Full Text] [Related]
33. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
34. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
[TBL] [Abstract][Full Text] [Related]
35. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
Külkens S; Hacke W
Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
[TBL] [Abstract][Full Text] [Related]
36. Thrombolysis in stroke.
Vahedi K; Bousser MG
Curr Opin Hematol; 2002 Sep; 9(5):443-7. PubMed ID: 12172464
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
38. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
Samaniego EA; Linfante I; Dabus G
Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
[TBL] [Abstract][Full Text] [Related]
39. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
40. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]